Thomas Advanced Medical LLC
This multi-arm, multi-site study investigates the safety, tolerability, and efficacy of stem cell therapy for the treatment of various acute and chronic conditions. Clinically observed initial findings and an extensive body of research indicate regenerative treatments are both safe and effective for the treatment of multiple conditions.
Autoimmune Diseases
Cardiovascular Disorders
Diabetes Complications
Integumentary Disease
Musculoskeletal Disorders
Neurodegenerative Disorders
Neurologic Disorders
Pulmonary Disorders
Sexual Dysfunction
Urologic Disorders
Viral Illness
PrimePro™/ PrimeMSK™
PHASE1
PHASE2
This multi-arm, multi-site study investigates the safety, tolerability, and efficacy of stem cell therapy for the treatment of various acute and chronic conditions. Clinically observed initial findings and an extensive body of research indicate regenerative treatments are both safe and effective for the treatment of multiple conditions. This study investigates clinical outcomes of treatments for numerous indications including: Autoimmune, Cardiovascular, Diabetes, Integumentary, Neurologic / Neurodegenerative, Pulmonary, Orthopedic Diseases, Sexual Dysfunction, Urologic Disorders and Viral Illnesses. Our hypotheses posit that regenerative treatments are both safe and statistically beneficial for a range of conditions. Outcomes will be determined by multiple valid outcome instruments that measure general quality of life information along with condition-specific information.
| Study Type : | INTERVENTIONAL |
| Estimated Enrollment : | 5000 participants |
| Masking : | NONE |
| Primary Purpose : | TREATMENT |
| Official Title : | Evaluation of the Safety, Tolerability and Efficacy of Regenerative Therapy for the Treatment of Various Chronic and Acute Conditions |
| Actual Study Start Date : | 2020-07-09 |
| Estimated Primary Completion Date : | 2030-07-09 |
| Estimated Study Completion Date : | 2030-12-09 |
Information not available for Arms and Intervention/treatment
| Ages Eligible for Study: | 18 Years |
| Sexes Eligible for Study: | ALL |
| Accepts Healthy Volunteers: | 1 |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
RECRUITING
Southern California Hospital at Culver City / Southern California Hospital at Hollywood / Multiple US-based Sub-Investigator Sites
Culver City, California, United States, 92032